¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"stem cell factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾
crescent cell anemia
Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
helper cell activity
µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
islet cell adenoma
¼¶¼¼Æ÷»ùÁ¾
large cell acanthoma
Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
red cell aplasia
ÀûÇ÷±¸¹«Çü¼º
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
subependymal giant cell astrocytoma
³ú½Ç¸·¹Ø°Å´ë¼¼Æ÷º°¼¼Æ÷Á¾, »óÀÇÇϰŴ뼼Æ÷º°¼¼Æ÷Á¾
target cell anemia
Ç¥ÀûÀûÇ÷±¸ºóÇ÷
balloon cell
dz¼±¼¼Æ÷
balloon cell melanoma
dz¼±¼¼Æ÷Èæ»öÁ¾
balloon cell nevus
dz¼±¼¼Æ÷¸ð¹Ý
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
Heidenhain s cell
ÇÏÀ̵§ÇÏÀμ¼Æ÷.
Henle s cell
Çî·¯¼¼Æ÷.
Hfr cell
°íºóµµÀçÁ¶ÇÕ¼¼Æ÷
Hulle cell
¿ÜÇǼ¼Æ÷
ICSH = interstitial cell stimulating hormone
°£Áú¼¼Æ÷ÀÚ±Ø(Êàòõá¬øàí©Ð½)È£¸£¸ó.
ICSH=£¾interstitial cell stimulating hormone
°£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó.
K cell
K¼¼Æ÷, »ìÇØ¼¼Æ÷
LE cell
LE¼¼Æ÷.
LE cell phenomenon
LE¼¼Æ÷Çö»ó.
Langerhans cell
¶û°Ô¸£Çѽº¼¼Æ÷.
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸Áõ
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
Langerhans giant cell
¶û±×Çѽº°Å¼¼Æ÷
Langhans giant cell
¶û±×Çѽº°Å´ë¼¼Æ÷
Leydig cell
·¹À̵ðÈ÷ ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷¼º ÀÌ¿ÏÀÎÀÚ.
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷¼º ÀÌ¿ÏÀÎÀÚ(¡ì¬èÐì×í).
endothelium-derived relaxing factor
³»ÇÇ ¼¼Æ÷¼º ÀÌ¿ÏÀÎÀÚ
endothelium-derived relaxing factor (EDRF)
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ
endurance factor =EF
Áö¼ÓÀÎÀÚ(ò¥áÙì×í).
environmental chemotactic factor
ȯ°æ¼ºÈÇÐÁÖ¼ºÀÎÀÚ(ü»ÌÑàõûùùÊñËàõì×í)
environmental factor
ȯ°æÀÎÀÚ.
eosinophil chemotactic factor
È£»ê±¸ ÈÇÐÁÖ¼ºÀÎÀÚ
eosinophil chemotactic factor =ECF
È£»ê±¸ ÈÇÐÁÖ¼ºÀÎÀÚ.
eosinophilic chemotactic factor
È£»ê±¸¼º ÈÇÐÁÖ¼ºÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ(øúù«à÷íþì×í)
epidermal growth factor
Ç¥ÇǼºÀå ÀÎÀÚ(¡à÷íþ ì×í)
epidermal growth factor (EGF)
ÇǺÎÁõ½ÄÀÎÀÚ
epidermal growth factor = EGF
Ç¥ÇÇ ¼ºÀå ÀÎÀÚ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½